CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


28-August-2012
Introducing Certified Spiking Solutions® of the new antidepressant Vilazodone HCl & the tetracyclic antidepressant metabolite N-Desmethylmirtazapine.

Vilazodone HCl, 1.0 mg/mL V-023
1.0 mg/mL (as free base) in Methanol

A certified solution standard suitable for use in LC/MS or GC/MS applications for pharmaceutical research, clinical toxicology, or forensic testing. Marketed as the antidepressant drug Viibryd®, vilazodone is a new serotonin reuptake inhibitor approved by the US Food and Drug Administration (FDA) on January 21, 2011, for the treatment of major depressive disorder.

N-Desmethylmirtazapine, D-086
1.0 mg/mL in Acetonitrile

N-Desmethylmirtazapine is the major urinary metabolite of the tetracyclic antidepressant mirtazapine, marketed under the trade names Remeron, Avanza, or Zispin for treatment of depression. The metabolite, also known as normirtazapine, is pharmacologically active. This Certified Spiking Solution® is suitable for LC/MS or GC/MS methods in mirtazapine testing for forensic analysis, clinical toxicology, or urine drug testing.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn